Bhanu K. Sadasivan, PhD
Subscribe to Bhanu K. Sadasivan, PhD's PostsBhanu K. Sadasivan, PhD, focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software. Read Bhanu K. Sadasivan's full bio.
McDermott IP Focus 2024 | Session 1: The Weaponization of Prosecution Laches
By William Gaede and Bhanu K. Sadasivan, PhD on Feb 13, 2024
Posted In Uncategorized
McDermott is committed to providing insightful commentary on intellectual property (IP) developments from around the world to our Japanese clients. In light of that effort, we are pleased to announce that our free webinar series, McDermott IP Focus, will continue in 2024. During these sessions, we will explore global developments in IP, including disputes, transactions,...
Continue Reading
Time Bar Dismissal Saves Patent Found Unpatentable
By Bhanu K. Sadasivan, PhD on May 26, 2022
Posted In Patents
The US Court of Appeals for the Federal Circuit dismissed an appeal, finding it lacked appellate jurisdiction to review a Patent Trial & Appeal Board (Board) decision to vacate an institution decision of inter partes review (IPR) based in part on the Board’s time bar evaluation. Atlanta Gas Light Co. v. Bennet Regulator Guards, Inc.,...
Continue Reading
Court’s Drug Patent Prescription: Unclaimed Disclosure is Dedicated
By Bhanu K. Sadasivan, PhD on May 19, 2020
Posted In Patents
Addressing the disclosure-dedication doctrine, the US Court of Appeals for the Federal Circuit concluded that the disclosure-dedication doctrine barred a patent owner’s claim of infringement under the doctrine of equivalents because the asserted patents disclose, but do not claim, the alleged equivalent. Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, Case No. 19-1924 (Fed. Cir. May...
Continue Reading
